Lipid-driven immunometabolic responses in atherosclerosis

Current Opinion in Lipidology
Anton Gisterå, Daniel F J Ketelhuth

Abstract

Atherosclerosis is a chronic inflammatory disease in which subendothelial infiltration of lipoproteins leads to inflamed lesions in arteries. Despite improvements in secondary prevention, most cardiovascular events cannot be avoided with current therapies. This review focuses on novel mechanistic insights on lipid-driven immune activation, which could pave the way for new anti-inflammatory treatments for atherosclerosis. Immunometabolic interactions can shape the immune response. Within atherosclerotic plaques, macrophages and T cells are the dominant immune cell populations. Using multiple mechanisms, lipoprotein-derived components activate both the innate and adaptive immune systems. Cholesterol crystals and apolipoprotein B-peptides have been shown to activate macrophages and T cells, respectively. Lipoproteins are also important modulators of regulatory T cells that can hamper vascular inflammation. In the liver, T cells can influence hepatic inflammation and lipoprotein metabolism. Hence, there is an intricate crosstalk between the immune system and lipoprotein metabolism. Novel treatments are needed to prevent clinical manifestations of atherosclerosis. Improved understanding of lipid-driven immunometabolic responses is l...Continue Reading

References

May 6, 2003·Journal of Lipid Research·Charles A Strott, Yuko Higashi
Oct 7, 2005·Nature·Peter van den ElzenMichael B Brenner
Apr 14, 2007·Science·James C LoYang-Xin Fu
Feb 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ryan D MichalekJeffrey C Rathmell
Jun 22, 2011·Circulation·Elena Maganto-GarcíaAndrew H Lichtman
Oct 24, 2012·The Journal of Biological Chemistry·Eszter MolnárWolfgang W A Schamel
Dec 4, 2012·Mini Reviews in Medicinal Chemistry·Palash PalMange Ram Yadav
Feb 22, 2013·The Journal of Clinical Investigation·Roland KlingenbergGöran K Hansson
Jan 15, 2014·Frontiers in Immunology·Kevin TseKlaus Ley
Feb 20, 2016·Circulation Research·Daniel F J Ketelhuth, Göran K Hansson
Apr 8, 2016·Science Translational Medicine·Sebastian ZimmerEicke Latz
Oct 30, 2016·Science·Bennett G ChildsJan M van Deursen
Jan 28, 2017·Nature Reviews. Cardiology·Godfrey S Getz, Catherine A Reardon
Mar 31, 2017·Nature Reviews. Molecular Cell Biology·Erdinc SezginChristian Eggeling
Apr 11, 2017·Nature Reviews. Nephrology·Anton Gisterå, Göran K Hansson
Apr 20, 2017·Circulation Research·Reiner K W MailerGöran K Hansson
Jul 7, 2017·Cell Metabolism·Tomasz Próchnicki, Eicke Latz
Jul 18, 2017·Journal of the American Heart Association·Paul C DimayugaKuang-Yuh Chyu
Aug 29, 2017·The New England Journal of Medicine·Paul M RidkerUNKNOWN CANTOS Trial Group
Oct 13, 2017·The Journal of Experimental Medicine·Hua JiangRongbin Zhou
Jan 6, 2018·Circulation Research·Jaume AmengualEdward A Fisher
Feb 9, 2018·International Journal of Molecular Sciences·Savitha SubramanianCatherine A Reardon
Mar 17, 2018·Nature Communications·Dalia E GaddisCatherine C Hedrick

❮ Previous
Next ❯

Citations

Oct 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Jacqueline S DronRobert A Hegele
Oct 22, 2019·Journal of Internal Medicine·I NarverudK B Holven
May 28, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Ying ShaoXiaofeng Yang
Aug 15, 2020·Journal of Internal Medicine·R BaumgartnerD F J Ketelhuth
Dec 2, 2018·Journal of Oncology·Maiko Matsushita, Mai Kawaguchi
Nov 5, 2019·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Chan-Juan ZhangLi Qin
Jul 14, 2021·Nature Reviews. Cardiology·Nathalie A ReillyJ Wouter Jukema
Jul 26, 2021·International Immunopharmacology·Rana M AlsaffarMuneeb U Rehman
Jul 22, 2021·Journal of Cellular Physiology·Yu-Sheng QinChao-Ke Tang
Aug 28, 2021·International Journal of Molecular Sciences·Diana SalnikovaAlexander Orekhov

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Nature Reviews. Nephrology
Anton Gisterå, Göran K Hansson
Clinica Chimica Acta; International Journal of Clinical Chemistry
Anusha N SeneviratneClaudia Monaco
Current Vascular Pharmacology
Anusha N Seneviratne, Claudia Monaco
© 2022 Meta ULC. All rights reserved